Vidofludimus calcium for the treatment of multiple sclerosis: development rationale, mechanism of action, and early trial data.

Ondrus M, Fox RJ, Peelen E, Fonseca J, Sciacca V, Sanchez-Gomez I, Arend J, Herrmann A, Samcova M, Gege C, et al.

Expert Opin Investig Drugs. 2026 Jul 16. PMID: 42461014. Abstract